Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history.

Arora H, Willcocks RJ, Lott DJ, Harrington AT, Senesac CR, Zilke KL, Daniels MJ, Xu D, Tennekoon GI, Finanger EL, Russman BS, Finkel RS, Triplett WT, Byrne BJ, Walter GA, Sweeney HL, Vandenborne K.

Muscle Nerve. 2018 Nov;58(5):631-638. doi: 10.1002/mus.26161. Epub 2018 Jul 24.

PMID:
29742798
2.

Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.

Barnard AM, Willcocks RJ, Finanger EL, Daniels MJ, Triplett WT, Rooney WD, Lott DJ, Forbes SC, Wang DJ, Senesac CR, Harrington AT, Finkel RS, Russman BS, Byrne BJ, Tennekoon GI, Walter GA, Sweeney HL, Vandenborne K.

PLoS One. 2018 Mar 19;13(3):e0194283. doi: 10.1371/journal.pone.0194283. eCollection 2018.

3.

Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.

Willcocks RJ, Rooney WD, Triplett WT, Forbes SC, Lott DJ, Senesac CR, Daniels MJ, Wang DJ, Harrington AT, Tennekoon GI, Russman BS, Finanger EL, Byrne BJ, Finkel RS, Walter GA, Sweeney HL, Vandenborne K.

Ann Neurol. 2016 Apr;79(4):535-47. doi: 10.1002/ana.24599. Epub 2016 Feb 19.

4.

Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.

Forbes SC, Willcocks RJ, Triplett WT, Rooney WD, Lott DJ, Wang DJ, Pollaro J, Senesac CR, Daniels MJ, Finkel RS, Russman BS, Byrne BJ, Finanger EL, Tennekoon GI, Walter GA, Sweeney HL, Vandenborne K.

PLoS One. 2014 Sep 9;9(9):e106435. doi: 10.1371/journal.pone.0106435. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e111822.

5.

Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS.

Arpan I, Willcocks RJ, Forbes SC, Finkel RS, Lott DJ, Rooney WD, Triplett WT, Senesac CR, Daniels MJ, Byrne BJ, Finanger EL, Russman BS, Wang DJ, Tennekoon GI, Walter GA, Sweeney HL, Vandenborne K.

Neurology. 2014 Sep 9;83(11):974-80. doi: 10.1212/WNL.0000000000000775. Epub 2014 Aug 6.

6.

Mutations in γ adducin are associated with inherited cerebral palsy.

Kruer MC, Jepperson T, Dutta S, Steiner RD, Cottenie E, Sanford L, Merkens M, Russman BS, Blasco PA, Fan G, Pollock J, Green S, Woltjer RL, Mooney C, Kretzschmar D, Paisán-Ruiz C, Houlden H.

Ann Neurol. 2013 Dec;74(6):805-14. doi: 10.1002/ana.23971.

7.

A comparison of the changes in the energy cost of walking between children with cerebral palsy and able-bodied peers over one year.

Thomas SS, Buckon CE, Russman BS, Sussman MD, Aiona MD.

J Pediatr Rehabil Med. 2011;4(3):225-33. doi: 10.3233/PRM-2011-0178.

PMID:
22207099
8.

Definition and classification of hyperkinetic movements in childhood.

Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, Singer HS, Alter K, Ben-Pazi H, Butler EE, Chen R, Collins A, Dayanidhi S, Forssberg H, Fowler E, Gilbert DL, Gorman SL, Gormley ME Jr, Jinnah HA, Kornblau B, Krosschell KJ, Lehman RK, MacKinnon C, Malanga CJ, Mesterman R, Michaels MB, Pearson TS, Rose J, Russman BS, Sternad D, Swoboda KJ, Valero-Cuevas F.

Mov Disord. 2010 Aug 15;25(11):1538-49. doi: 10.1002/mds.23088. Review.

9.

Intrathecal baclofen.

Russman BS.

Dev Med Child Neurol. 2010 Jul;52(7):601-2. doi: 10.1111/j.1469-8749.2009.03515.x. Epub 2009 Oct 14. No abstract available.

10.

Variability and minimum detectable change for walking energy efficiency variables in children with cerebral palsy.

Thomas SS, Buckon CE, Schwartz MH, Russman BS, Sussman MD, Aiona MD.

Dev Med Child Neurol. 2009 Aug;51(8):615-21. doi: 10.1111/j.1469-8749.2008.03214.x.

11.

Continuous intrathecal baclofen infusion for intractable spastic cerebral palsy--is it worth it?

Russman BS.

Nat Clin Pract Neurol. 2008 Sep;4(9):476-7. doi: 10.1038/ncpneuro0868. Epub 2008 Jul 29.

PMID:
18665144
12.

Systematic review of hyperbaric oxygen therapy for cerebral palsy: the state of the evidence.

McDonagh MS, Morgan D, Carson S, Russman BS.

Dev Med Child Neurol. 2007 Dec;49(12):942-7. Review.

13.

Spinal muscular atrophy: clinical classification and disease heterogeneity.

Russman BS.

J Child Neurol. 2007 Aug;22(8):946-51. Review.

PMID:
17761648
14.

Cerebral palsy--are the definitions of the Gross Motor Functional Classification System too broad?

Russman BS.

Nat Clin Pract Neurol. 2007 Jun;3(6):314-5. Epub 2007 May 1. No abstract available.

PMID:
17471280
15.

Validation of a care and comfort hypertonicity questionnaire.

Nemer McCoy R, Blasco PA, Russman BS, O'Malley JP.

Dev Med Child Neurol. 2006 Mar;48(3):181-7.

16.

Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.

Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, Sanders J, D'Astous J, Aiona MD; Shriners Hospitals BTX-A Study Group.

Dev Med Child Neurol. 2005 Sep;47(9):620-7.

PMID:
16138670
17.

Development of an interest in spinal muscular atrophy and disabilities.

Russman BS.

Dev Med Child Neurol. 2005 Sep;47(9):579. No abstract available.

PMID:
16138661
18.

Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke.

McDonagh M, Carson S, Ash J, Russman BS, Stavri PZ, Krages KP, Helfand M.

Evid Rep Technol Assess (Summ). 2003 Sep;(85):1-6. Review. No abstract available.

19.

Hyperbaric oxygen therapy for traumatic brain injury: a systematic review of the evidence.

McDonagh M, Helfand M, Carson S, Russman BS.

Arch Phys Med Rehabil. 2004 Jul;85(7):1198-204. Review.

PMID:
15241774
20.

Evaluation of the child with cerebral palsy.

Russman BS, Ashwal S.

Semin Pediatr Neurol. 2004 Mar;11(1):47-57. Review.

PMID:
15132253
21.

Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M, Stevenson R; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society.

Neurology. 2004 Mar 23;62(6):851-63.

PMID:
15037681
22.

A phase 1 trial of riluzole in spinal muscular atrophy.

Russman BS, Iannaccone ST, Samaha FJ.

Arch Neurol. 2003 Nov;60(11):1601-3.

PMID:
14623733
23.

Cerebral Palsy.

Russman BS.

Curr Treat Options Neurol. 2000 Mar;2(2):97-108.

PMID:
11096740
24.

Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group.

Iannaccone ST, Russman BS, Browne RH, Buncher CR, White M, Samaha FJ.

J Child Neurol. 2000 Feb;15(2):97-101.

PMID:
10695894
25.

Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment.

Russman BS, Tilton A, Gormley ME Jr.

Muscle Nerve Suppl. 1997;6:S181-93. Review.

PMID:
9826990
26.

Function changes in spinal muscular atrophy II and III. The DCN/SMA Group.

Russman BS, Buncher CR, White M, Samaha FJ, Iannaccone ST.

Neurology. 1996 Oct;47(4):973-6.

PMID:
8857729
27.

Magnetic resonance imaging for spinal muscular atrophy.

Russman BS.

J Child Neurol. 1995 Mar;10(2):174. No abstract available.

PMID:
7782611
28.

Pulmonary function in spinal muscular atrophy.

Samaha FJ, Buncher CR, Russman BS, White ML, Iannaccone ST, Barker L, Burhans K, Smith C, Perkins B, Zimmerman L.

J Child Neurol. 1994 Jul;9(3):326-9.

PMID:
7930415
29.

Neuromuscular diseases of childhood.

Russman BS, Schwartz RC.

Curr Opin Pediatr. 1993 Dec;5(6):669-74. Review.

PMID:
8124418
30.

Folate deficiency and acute intermittent porphyria in a 12-year-old boy.

DiMario FJ Jr, Quinn JJ, Zalneraitis EL, Whiteman DA, Russman BS.

Neurology. 1993 Jul;43(7):1438-9. No abstract available.

PMID:
8327156
31.

Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema.

Russman BS, Iannacone ST, Buncher CR, Samaha FJ, White M, Perkins B, Zimmerman L, Smith C, Burhans K, Barker L.

J Child Neurol. 1992 Oct;7(4):347-53.

PMID:
1469240
32.

What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girl.

Russman BS, Lang AE, Fahn S, Greene P, Grunnet ML.

Mov Disord. 1992 Oct;7(4):373-9. No abstract available.

PMID:
1336568
33.

Muscle biopsy and the clinical course of infantile spinal muscular atrophy.

Zalneraitis EL, Halperin JJ, Grunnet ML, Russman BS, Peress N.

J Child Neurol. 1991 Oct;6(4):324-8.

PMID:
1940134
34.

Sources of information used in diagnosing childhood learning disabilities.

Brunquell PJ, Russman BS, Lerer TJ.

Pediatr Neurol. 1991 Sep-Oct;7(5):342-6.

PMID:
1764135
35.

Spasticity in cerebral palsy and the selective posterior rhizotomy procedure.

Russman BS, Gahm NH.

J Child Neurol. 1991 Jul;6(3):277-8. No abstract available.

PMID:
1875032
36.

Juvenile Leigh's encephalomyelopathy with peripheral neuropathy, myopathy, and cardiomyopathy.

Grunnet ML, Zalneraitis EL, Russman BS, Barwick MC.

J Child Neurol. 1991 Apr;6(2):159-63.

PMID:
1646254
37.

Rehabilitation of the pediatric patient with a neuromuscular disease.

Russman BS.

Neurol Clin. 1990 Aug;8(3):727-40. Review.

PMID:
2145506
38.

Differentiation of epileptic from nonepileptic head drops in children.

Brunquell P, Mc Keever M, Russman BS.

Epilepsia. 1990 Jul-Aug;31(4):401-5.

PMID:
2369876
39.

A methodology to measure the strength of SMA patients. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.

Cook JD, Iannaccone ST, Russman BS, Samaha F, Buncher RR, Ross D, Hare M, Smith C, Perkins B, Zimmerman L, et al.

Muscle Nerve. 1990;13 Suppl:S7-10. No abstract available.

PMID:
2233889
40.

Statistical considerations in the study of spinal muscular atrophy. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.

Buncher CR, Samaha F, Iannaccone ST, Russman BS, Cook JD, White M, McLaughlin C.

Muscle Nerve. 1990;13 Suppl:S45-8. No abstract available.

PMID:
2233886
41.

Sensitivity of the DCN-SMA Study Group methodology. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.

Russman BS, Iannaccone ST, Cook JD, Buncher RR, Samaha F, Perkins B, Zimmerman L.

Muscle Nerve. 1990;13 Suppl:S13-5. No abstract available.

PMID:
2233876
42.

Preliminary observations on the reliability of the DCN-SMA Study Group methodology. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.

Samaha F, Cook JD, Iannaccone ST, Russman BS, Buncher RR, Barker L, Burhans K.

Muscle Nerve. 1990;13 Suppl:S11-2. No abstract available.

PMID:
2233875
43.

Cerebral palsy.

Russman BS, Gage JR.

Curr Probl Pediatr. 1989 Feb;19(2):65-111. Review. No abstract available.

PMID:
2651017
44.

Mental status examination of children with learning problems.

Brunquell PJ, Russman BS, Lerer TJ.

Pediatr Neurol. 1989 Jan-Feb;5(1):32-6.

PMID:
2712936
45.

Are infant stimulation programs useful?

Russman BS.

Arch Neurol. 1986 Mar;43(3):282-3. No abstract available.

PMID:
3947279
46.
47.

Human serum teratogenicity studied by rat embryo culture: epilepsy, anticonvulsant drugs, and nutrition.

Chatot CL, Klein NW, Clapper ML, Resor SR, Singer WD, Russman BS, Holmes GL, Mattson RH, Cramer JA.

Epilepsia. 1984 Apr;25(2):205-16.

PMID:
6705751
48.

Comprehensive management of children with muscular disorders.

Russman BS.

Pediatr Ann. 1984 Feb;13(2):103, 108, 110-2.

PMID:
6709402
49.

Speech abnormalities in seizures: a comparison of absence and partial complex seizures.

McKeever M, Holmes GL, Russman BS.

Brain Lang. 1983 May;19(1):25-32.

PMID:
6407722
50.

Spinal muscular atrophy: the natural course of disease.

Russman BS, Melchreit R, Drennan JC.

Muscle Nerve. 1983 Mar-Apr;6(3):179-81.

PMID:
6855803

Supplemental Content

Loading ...
Support Center